Chemical Space Exploration: Smart Discovery of Novel Drug Candidates

webinar

Wed, 14 Sep 2022, 16:00 CEST (Berlin)

Alexander Neumann, BioSolveIT

Chemical Space Exploration: Smart Discovery of Novel Drug Candidates

The Chemical Space is vast and bears almost endless possibilities to address challenges in modern drug discovery. Through combination of building blocks by applying chemistry rules large sets of synthetically accessible molecules can be created. Yet, due to its sheer size, novel methods to explore and navigate the Chemical Space are required to extract molecules of interest out of the myriad of compounds. In this workshop the basics of Chemical Space generation, benefits of combinatorial methods, and subsequent assessment for the best candidates will be discussed and elucidated.
Join us for the exciting workshop showcasing how to approach modern drug discovery beyond the limits of enumeration.
Participants can request a certificate of attendance.

Current news

VAST Just Got Bigger — The September 2026 Update
September 17, 2026 09:00 CEST
More compounds. More chemistry. More opportunities to discover your next active. This August, explore Enamine’s largest compound catalog with infiniSee xREAL as BioSolveIT’s Tool of the Month. XtalPi has expanded its VAST Chemical Space, giving you access to almost six billion virtual product molecules built from over 25,000 carefully selected...
Read on
category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on